Retlirafusp Alfa Human Monoclonal Antibody
Retlirafusp Alfais a research-grade recombinant antibody targeting CD1. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
B7-H1, Programmed cell death 1 ligand 1, PDCD1 ligand 1, PDCD1L1, B7 homolog 1, PDCD1LG1, PDL1, hPD-L1, Programmed death ligand 1, B7H1, PD-L1, CD274, TGFR-2, TbetaR-II, TGF-beta type II receptor, TGFBR2, TGF-beta receptor type-2, TGF-beta receptor type II, Transforming growth factor-beta receptor type II
UniProt
P37173, Q9NZQ7
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG4-kappa
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7115113-01 0.01 mg
Recombinant Human T-Lymphocyte Activation Antigen CD86 (CD86), Partial
Sign In for Pricing
View Details MBS7115113-02 0.05 mg
Recombinant Human T-Lymphocyte Activation Antigen CD86 (CD86), Partial
Sign In for Pricing
View Details MBS7115113-03 0.5 mg
Recombinant Human T-Lymphocyte Activation Antigen CD86 (CD86), Partial
Sign In for Pricing
View Details MBS7115113-04 1 mg
Recombinant Human T-Lymphocyte Activation Antigen CD86 (CD86), Partial
Sign In for Pricing
View Details MBS7115113-05 5x 1 mg
Recombinant Human T-Lymphocyte Activation Antigen CD86 (CD86), Partial
Sign In for Pricing
View Details